You have successfully sign out
Loading...
Cyclo Therapeutics, Inc.
CYTHW
Company Description
Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease. The company was founded by Charles E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL.
Â
NASDAQ
0.18USD
0.01Â ( 3.67%)
Pre-market 0.21$0.00 (0.00%)Market Closed (as of Mar 13, 20:00 EDT)
Relative Strenght
91
Volume Buzz
-96%
Earning Acce
No
Dist 52w H.
71%
